Literature DB >> 7500236

Otitis media in early childhood and cognitive, academic, and behavior outcomes at 12 years of age.

J E Roberts1, M R Burchinal, S M Clarke-Klein.   

Abstract

Examined the association between otitis media with effusion (OME) during the first 3 years of life and cognitive and academic performance and behavioral outcomes at 12 years of age in 56 socioeconomically disadvantaged children attending a research childcare program. OME history was prospectively documented from birth through 3 years during well and illness periods. Standardized tests of intelligence and academic achievement and measures of behavior were administered when children were 12 years of age. OME during early childhood was not related to intellectual performance, academic achievement, behavior, or attention. Results do not support a long-term relationship between a history of OME and later developmental outcomes. Generalizations of these findings to other populations should be done cautiously.

Entities:  

Mesh:

Year:  1995        PMID: 7500236     DOI: 10.1093/jpepsy/20.5.645

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  4 in total

1.  Influences on clinical practice: the case of glue ear.

Authors:  S Dopson; R Miller; S Dawson; K Sutherland
Journal:  Qual Health Care       Date:  1999-06

2.  Behaviour and developmental effects of otitis media with effusion into the teens.

Authors:  K E Bennett; M P Haggard; P A Silva; I A Stewart
Journal:  Arch Dis Child       Date:  2001-08       Impact factor: 3.791

3.  Glue ear, hearing loss and IQ: an association moderated by the child's home environment.

Authors:  Amanda J Hall; Richard Maw; Elizabeth Midgley; Jean Golding; Colin Steer
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

4.  Sustained Auditory Attention Ability Test (SAAAT) in seven-year-old children with cleft lip and palate.

Authors:  Isabel Cristina Cavalcanti Lemos; Mariza Ribeiro Feniman
Journal:  Braz J Otorhinolaryngol       Date:  2010 Mar-Apr
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.